ArticleCancer biology & therapy2010

Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology.

Daniel E Abbott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.